× |
|
Remission Rates in Patients With Anxiety Disorders Treated With Paroxetine PDF |
$40.00 |
|
$40.00 |
× |
|
Suicidal Risk Factors in Bipolar I and II Disorder Patients PDF |
$40.00 |
|
$40.00 |
× |
|
Early Prediction of Antipsychotic Nonresponse Among Patients With Schizophrenia. PDF |
$40.00 |
|
$40.00 |
× |
|
Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression PDF |
$40.00 |
|
$40.00 |
× |
|
Antidepressant-Induced Mania in Bipolar Patients: Identification of Risk Factors PDF |
$40.00 |
|
$40.00 |
× |
|
Number Needed to Treat to Harm for Discontinuation Due to Adverse Events in the Treatment of Bipolar Depression, Major Depressive Disorder, and Generalized Anxiety Disorder With Atypical Antipsychotics PDF |
$40.00 |
|
$40.00 |
× |
|
The Emergence of Social Phobia During Clozapine Treatment and Its Response to Fluoxetine Augmentation PDF |
$40.00 |
|
$40.00 |
|